Clinical Trial Update: A Dose-Ranging Study of the Safety and Efficacy of ADX415 in the Treatment of Essential Hypertension [Phase 2]

View source ↗

Summary

Phase 2 dose-ranging study evaluating the safety and efficacy of ADX415 in essential hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• ADX415

Snippet

Sponsor: Addrenex Pharmaceuticals, Inc. | Conditions: Hypertension | Phase 2 | Status: COMPLETED